efe-epaSydney, Australia
10 Dec 2020
A health worker dressed in Personal Protective Equipment (PPE) looks out of a bus as overseas Australians arrive for mandatory 14-day hotel quarantine at the Pacific Hotel in Canberra, Australia, 26 November 2020. EPA-EFE/MICK TSIKAS AUSTRALIA AND NEW ZEALAND OUT
Health workers dressed in Personal Protective Equipment (PPE) wait for overseas Australians to arrive for mandatory 14-day hotel quarantine at the Pacific Hotel in Canberra, Australia, 26 November 2020. EPA-EFE/MICK TSIKAS AUSTRALIA AND NEW ZEALAND OUT
An Australian woman and her baby exit a bus as they arrive for mandatory 14-day hotel quarantine at the Pacific Hotel in Canberra, Australia, 26 November 2020. EPA-EFE/MICK TSIKAS AUSTRALIA AND NEW ZEALAND OUT
New process can trace Covid-19 cases within four hours
bangkokpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bangkokpost.com Daily Mail and Mail on Sunday newspapers.
Covid-19 scare on cruise ship shows perils of resuming tourism
hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.
Synedgen Partnership with the University of New South Wales Receives Australian Research Council (ARC) Grant
- Grant will fund understanding of
the biochemical and biophysical structure of the endothelial glycocalyx -
- Synedgen’s CEO, Shenda Baker, gave a related keynote lecture at the Pan Pacific Connective Tissue Societies Symposium on November 25, 2020 -
CLAREMONT, Calif. (BUSINESS WIRE) Synedgen, a biotechnology company using glycopolymer chemistry to develop drugs that enhance and control signaling in the innate immune system, today announced that UNSW in partnership with Synedgen has been awarded an A$600,633, 3-year, research grant from the Australian Research Council (ARC) to advance knowledge of the biochemical and biophysical structure of the endothelial glycocalyx. The resulting study will be the first to explore how charged glycopolymers interact with the endothelial glycocalyx with the goal of mapping the lifecycle of the network of membrane-bound proteoglycans a